HFE (Q30201) variants and mutations
HFE (also known as Q30201) is a human protein-coding gene encoding a hereditary hemochromatosis protein. It helps the liver sense circulating iron availability and regulate hepcidin, thereby controlling intestinal iron absorption and systemic iron distribution. The C282Y variant is the major genetic cause of HFE-related hereditary hemochromatosis and progressive iron overload. This analysis covers 681 HFE variants and mutations. Of these, 80% have computational variant effect predictions. Disease context includes hemochromatosis type 1, hereditary hemochromatosis, and familial porphyria cutanea tarda. Example HFE variants include G2S, G2R, and G2A.
Variant analysis overview
- Gene: HFE
- Protein: Q30201
- UniProt accession: Q30201
- Organism: Homo sapiens
- Variants analyzed: 681
- Variant scope: all variants
- Completed: 2026-08-10
Variant and mutation evidence
- Variant composition: 418 unspecified-consequence records; 112 missense variants; 116 synonymous variants; 3 in-frame deletions; 15 frameshift variants; 8 stop-gained variants; 4 splice-region variants; 1 in-frame insertions; 4 substitution
- Prediction scores: 548 variants have prediction scores (80% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: hemochromatosis type 1, hereditary hemochromatosis, familial porphyria cutanea tarda, variegate porphyria, Alzheimer disease type 1, hemochromatosis, cardiomyopathy, cystic fibrosis, hereditary disease, Alzheimer disease, porphyria cutanea tarda, metabolic disease.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 1 domains; 3 post-translational modification sites.
- Structural context: 211 variants have structural context.
- PTM context: 6 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable HFE variants
Examples include G2S, G2R, G2A, G2G, P3L, P3S, P3R, P3P. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- G2S (p.Gly2Ser), cosmic curated COSV10642, ExAC rs774304096, gnomAD rs774304096, REVEL 0.03, CADD 14.70
- G2R (p.Gly2Arg), gnomAD 6-26087444-G-C, REVEL 0.03, MetaLR 0.31
- G2A (p.Gly2Ala), gnomAD 6-26087445-G-C, REVEL 0.08, MetaLR 0.30
- G2G (p.Gly2Gly), rs558658016, gnomAD 6-26087446-C-T, CADD 14.00
- P3L (p.Pro3Leu), rs1190491989, NCI-TCGA Cosmic COSV5851, cosmic curated COSV58513, gnomAD rs1190491989, REVEL 0.03, CADD 12.80, Variant assessed as somatic; moderate impact.
- P3S (p.Pro3Ser), gnomAD rs1762348630, REVEL 0.04, CADD 19.10
- P3R (p.Pro3Arg), gnomAD 6-26087448-C-G, REVEL 0.02, MetaLR 0.50
- P3P (p.Pro3Pro), rs1390702180, gnomAD 6-26087449-G-A, CADD 9.64
- R4G (p.Arg4Gly), ExAC rs772521418, gnomAD rs772521418, REVEL 0.06, CADD 19.50
- R4Q (p.Arg4Gln), Ensembl rs1762349552
- A5T (p.Ala5Thr), ExAC rs773593371, TOPMed rs773593371, gnomAD rs773593371
- A5V (p.Ala5Val), gnomAD rs1404018362, REVEL 0.10, CADD 23.80
- A5D (p.Ala5Asp), gnomAD 6-26087454-C-A, REVEL 0.16, MetaLR 0.68
- R6M (p.Arg6Met), Ensembl rs1762350545, Uncertain significance, in HFE1
- R6S (p.Arg6Ser), rs149342416, ClinGen CA338954, ClinVar RCV000199898, ClinVar RCV000329080, REVEL 0.22, CADD 16.40, Uncertain significance, Hemochromatosis type 1; Variegate porphyria; Microvascular complications of diab
- R6T (p.Arg6Thr), rs1762350545, ClinGen CA363202630, ClinVar RCV004544165, REVEL 0.08, CADD 15.70, Uncertain significance, HFE-related disorder
- R6W (p.Arg6Trp), Ensembl rs1762350317, Uncertain significance, in HFE1
- P7Q (p.Pro7Gln), ExAC rs766754409, TOPMed rs766754409, gnomAD rs766754409, REVEL 0.08, CADD 19.70, Uncertain significance
- P7R (p.Pro7Arg), rs766754409, ClinGen CA3666554, ClinVar RCV001759061, ClinVar RCV005057604, REVEL 0.04, CADD 19.40, Uncertain significance, Hereditary hemochromatosis; not provided
- P7P (p.Pro7Pro), rs114758821, gnomAD 6-26087461-G-A, CADD 9.38
- A8P (p.Ala8Pro), TOPMed rs903564153, gnomAD rs903564153, REVEL 0.20, CADD 21.80
- A8V (p.Ala8Val), rs999289975, ClinGen CA136289689, ClinVar RCV002971329, TOPMed rs999289975, REVEL 0.09, CADD 21.20, Uncertain significance, Hereditary hemochromatosis
- A8A (p.Ala8Ala), gnomAD 6-26087464-G-C, CADD 10.20
- L9F (p.Leu9Phe), ExAC rs763120100, gnomAD rs763120100, REVEL 0.05, CADD 16.70, Uncertain significance, Inborn genetic diseases
- L9P (p.Leu9Pro), TOPMed rs1762352373
- L9L (p.Leu9Leu), rs763602445, gnomAD 6-26087467-T-A, CADD 5.22
- L10H (p.Leu10His), NCI-TCGA Cosmic COSV5851, cosmic curated COSV58512, Variant assessed as somatic; moderate impact.
- L10P (p.Leu10Pro), ExAC rs751092414, gnomAD rs751092414
- L10V (p.Leu10Val), Ensembl rs1762352818
- L10L (p.Leu10Leu), rs368895240, gnomAD 6-26087470-C-T, CADD 5.68
- L11H (p.Leu11His), TOPMed rs1762353729
- L12M (p.Leu12Met), gnomAD rs1258155795, REVEL 0.06, CADD 17.30
- L12del (p.Leu12del), rs748197032, gnomAD 6-26087467-TCTC-T, CADD 12.70
- L12L (p.Leu12Leu), gnomAD 6-26087474-C-T, CADD 9.40
- M13K (p.Met13Lys), TOPMed rs1225546896, gnomAD rs1225546896, REVEL 0.09, CADD 18.30
- M13L (p.Met13Leu), ExAC rs781034120, gnomAD rs781034120
- M13T (p.Met13Thr), gnomAD 6-26087478-T-C, REVEL 0.05, MetaLR 0.20
- L14I (p.Leu14Ile), ExAC rs201657128, TOPMed rs201657128, gnomAD rs201657128, REVEL 0.04, CADD 13.50, Uncertain significance
- L14P (p.Leu14Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L14V (p.Leu14Val), rs201657128, ClinGen CA3666562, ClinVar RCV001157771, ClinVar RCV001247202, REVEL 0.03, CADD 13.00, Uncertain significance, Hereditary hemochromatosis; not provided; Hemochromatosis type 1
- L14L (p.Leu14Leu), gnomAD 6-26087482-T-C, CADD 10.30
- L15S (p.Leu15Ser), gnomAD rs1266453187, REVEL 0.07, CADD 23.30
- L15L (p.Leu15Leu), gnomAD 6-26087483-T-C, CADD 8.50
- Q16R (p.Gln16Arg), ExAC rs755930448, gnomAD rs755930448, REVEL 0.03, CADD 6.41
- Q16Q (p.Gln16Gln), gnomAD 6-26087488-G-A, CADD 9.65
- T17I (p.Thr17Ile), rs143662783, ClinGen CA3666564, ClinVar RCV000538099, ClinVar RCV000998545, REVEL 0.04, CADD 14.40, Uncertain significance, Hereditary hemochromatosis; Hemochromatosis type 1; not provided
- T17S (p.Thr17Ser), ESP rs143662783, ExAC rs143662783, TOPMed rs143662783, gnomAD rs143662783, REVEL 0.03, CADD 12.00, Uncertain significance
- T17A (p.Thr17Ala), gnomAD 6-26087489-A-G, REVEL 0.01, MetaLR 0.26
- T17T (p.Thr17Thr), rs953205703, gnomAD 6-26087491-C-A, CADD 8.28
- A18G (p.Ala18Gly), gnomAD 6-26087492-GC-G, CADD 19.50
- A18A (p.Ala18Ala), rs1432538644, gnomAD 6-26087494-G-T, CADD 12.30
- V19V (p.Val19Val), rs749460044, gnomAD 6-26087497-C-T, CADD 9.51
- L20R (p.Leu20Arg), ExAC rs779045932, gnomAD rs779045932, REVEL 0.03, CADD 10.90
- L20V (p.Leu20Val), ExAC rs768818817, gnomAD rs768818817, REVEL 0.03, CADD 7.08
- L20L (p.Leu20Leu), gnomAD 6-26087498-C-T, CADD 8.53
- L20Q (p.Leu20Gln), gnomAD 6-26087499-T-A, REVEL 0.03, MetaLR 0.40
- L20P (p.Leu20Pro), gnomAD 6-26087499-T-C, REVEL 0.05, MetaLR 0.29
- Q21H (p.Gln21His), ExAC rs772608361, gnomAD rs772608361
- Q21P (p.Gln21Pro), ExAC rs748215854, gnomAD rs748215854
- Q21E (p.Gln21Glu), gnomAD 6-26087501-C-G, REVEL 0.06, MetaLR 0.31
- Q21R (p.Gln21Arg), gnomAD 6-26087502-A-G, REVEL 0.07, MetaLR 0.41
- Q21Q (p.Gln21Gln), rs772608361, gnomAD 6-26087503-G-A, CADD 7.23
- Q21* (p.Gln21Ter), rs1762359467, gnomAD 6-26087516-C-T, REVEL 0.23, MetaLR 0.01
- G22R (p.Gly22Arg), ExAC rs773545645, gnomAD rs773545645, REVEL 0.05, CADD 16.40
- G22A (p.Gly22Ala), gnomAD 6-26087505-G-C, REVEL 0.07, MetaLR 0.28
- R23C (p.Arg23Cys), rs761203501, NCI-TCGA Cosmic COSV1003, cosmic curated COSV10035, ExAC rs761203501, REVEL 0.12, CADD 25.20, Variant assessed as somatic; moderate impact.
- R23H (p.Arg23His), rs148161858, ClinGen CA3666572, ClinVar RCV000296289, ClinVar RCV001095119, REVEL 0.05, CADD 23.20, Conflicting interpretations, Hereditary hemochromatosis; Hemochromatosis type 1; not provided
- R23L (p.Arg23Leu), rs148161858, ClinVar RCV004592185, 1000Genomes rs148161858, ESP rs148161858, REVEL 0.06, CADD 23.20, Uncertain significance, not provided
- R23R (p.Arg23Arg), gnomAD 6-26087509-C-G, CADD 9.22
- L24L (p.Leu24Leu), gnomAD 6-26087512-G-A, CADD 7.83
- R26C (p.Arg26Cys), TOPMed rs1762359467
- R26Q (p.Arg26Gln), rs894796712, []
- S27L (p.Ser27Leu), gnomAD rs1429701586, REVEL 0.25, CADD 23.40
- H28R (p.His28Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- H28Y (p.His28Tyr), TOPMed rs1762644334, gnomAD rs1762644334, REVEL 0.49, CADD 24.60
- H28H (p.His28His), rs766876606, gnomAD 6-26090848-C-T, CADD 7.87
- S29F (p.Ser29Phe), gnomAD 6-26090850-C-T, REVEL 0.53, MetaLR 0.87
- S29S (p.Ser29Ser), rs772911078, gnomAD 6-26090851-T-C, CADD 7.81
- L30M (p.Leu30Met), rs760685317, ClinGen CA363203858, ClinVar RCV001528692, ExAC rs760685317, REVEL 0.26, CADD 23.90, Uncertain significance, not provided
- L30Q (p.Leu30Gln), gnomAD rs1302552911, REVEL 0.30, CADD 25.40
- L30A (p.Leu30Ala), gnomAD 6-26090847-ACT-A, CADD 24.50
- L30L (p.Leu30Leu), rs760685317, gnomAD 6-26090852-C-T, CADD 11.00
- H31D (p.His31Asp), NCI-TCGA Cosmic COSV5851, cosmic curated COSV58512, Variant assessed as somatic; moderate impact.
- H31Y (p.His31Tyr), gnomAD 6-26090855-C-T, REVEL 0.08, MetaLR 0.00
- H31R (p.His31Arg), gnomAD 6-26090856-A-G, REVEL 0.15, MetaLR 0.00
- Y32H (p.Tyr32His), rs766458695, ExAC rs766458695, TOPMed rs766458695, gnomAD rs766458695, REVEL 0.15, CADD 26.70, Uncertain significance, Inborn genetic diseases
- Y32C (p.Tyr32Cys), gnomAD 6-26090859-A-G, REVEL 0.16, MetaLR 0.02
- L33L (p.Leu33Leu), rs753662663, gnomAD 6-26090863-C-T, CADD 12.60
- M35I (p.Met35Ile), rs1762646707, ClinGen CA363204026, ClinVar RCV002300778, TOPMed rs1762646707, REVEL 0.09, CADD 19.80, Uncertain significance, not provided
- M35T (p.Met35Thr), TOPMed rs2242956, REVEL 0.25, CADD 22.70
- M35V (p.Met35Val), gnomAD rs1762646075, REVEL 0.03, CADD 16.40
- G36D (p.Gly36Asp), rs1364493082, ClinGen CA363204053, ClinVar RCV001246359, TOPMed rs1364493082, REVEL 0.22, CADD 23.00, Uncertain significance, Hereditary hemochromatosis
- G36V (p.Gly36Val), TOPMed rs1364493082, gnomAD rs1364493082, REVEL 0.20, CADD 24.00, Uncertain significance
- G36P (p.Gly36Pro), rs1313557727, gnomAD 6-26090867-ATGGG-, CADD 28.40
- G36G (p.Gly36Gly), rs1234792167, gnomAD 6-26090872-T-C, CADD 1.73
- A37V (p.Ala37Val), rs377254261, ClinGen CA136291696, ClinVar RCV003211185, gnomAD rs377254261, REVEL 0.08, CADD 12.50, Uncertain significance, Inborn genetic diseases
- A37T (p.Ala37Thr), gnomAD 6-26090873-G-A, REVEL 0.13, MetaLR 0.00
- A37A (p.Ala37Ala), gnomAD 6-26090875-C-G, CADD 10.60
- S38P (p.Ser38Pro), gnomAD 6-26090876-T-C, REVEL 0.33, MetaLR 0.02
- S38S (p.Ser38Ser), gnomAD 6-26090878-A-C, CADD 2.46
- E39Q (p.Glu39Gln), gnomAD 6-26090879-G-C, REVEL 0.07, MetaLR 0.00
- Q40R (p.Gln40Arg), rs752497474, Ensembl rs752497474, REVEL 0.09, CADD 11.20, Variant assessed as somatic; moderate impact.
- Q40K (p.Gln40Lys), gnomAD 6-26090882-C-A, REVEL 0.13, MetaLR 0.23
- Q40P (p.Gln40Pro), gnomAD 6-26090883-A-C, REVEL 0.14, MetaLR 0.03
- D41N (p.Asp41Asn), Ensembl rs1762647785, Uncertain significance, Hereditary hemochromatosis
- L42F (p.Leu42Phe), gnomAD rs1272354878, REVEL 0.14, CADD 19.20
- G43C (p.Gly43Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact., in HFE1
- G43D (p.Gly43Asp), UniProt VAR 042507, Pathogenic, in HFE1
- G43R (p.Gly43Arg), gnomAD 6-26090891-G-C, REVEL 0.20, MetaLR 0.01
- G43V (p.Gly43Val), gnomAD 6-26090892-G-T, REVEL 0.16, MetaLR 0.01
- L44I (p.Leu44Ile), TOPMed rs1310863912, gnomAD rs1310863912, REVEL 0.12, CADD 24.40
- L44V (p.Leu44Val), gnomAD 6-26090894-C-G, REVEL 0.11, MetaLR 0.57
- L44R (p.Leu44Arg), gnomAD 6-26090895-T-G, REVEL 0.31, MetaLR 0.65
- L44P (p.Leu44Pro), gnomAD 6-26090895-T-C, REVEL 0.18, MetaLR 0.70
- L44L (p.Leu44Leu), rs754679371, gnomAD 6-26090896-T-G, CADD 9.42
- S45P (p.Ser45Pro), Ensembl rs1762649012
- L46F (p.Leu46Phe), Ensembl rs1762649644
- L46W (p.Leu46Trp), ExAC rs765114087, gnomAD rs765114087, REVEL 0.37, CADD 25.00
- L46L (p.Leu46Leu), rs1205608152, gnomAD 6-26090900-T-C, CADD 6.98
- L46S (p.Leu46Ser), gnomAD 6-26090901-T-C, REVEL 0.12, MetaLR 0.31
- A49S (p.Ala49Ser), rs2481601727, ClinGen CA363204367, ClinVar RCV003123388, Uncertain significance, not specified
- A49V (p.Ala49Val), gnomAD 6-26090910-C-T, REVEL 0.31, MetaLR 0.48
- L50F (p.Leu50Phe), gnomAD rs1482080398, REVEL 0.17, CADD 22.30
- L50C (p.Leu50Cys), gnomAD 6-26090911-TTTGGG, CADD 28.20
- L50V (p.Leu50Val), gnomAD 6-26090912-T-G, REVEL 0.09, MetaLR 0.00
- L50L (p.Leu50Leu), rs1482080398, gnomAD 6-26090914-G-A, CADD 8.21
- G51S (p.Gly51Ser), gnomAD rs1183193280, REVEL 0.33, CADD 25.70
- G51D (p.Gly51Asp), gnomAD 6-26090916-G-A, REVEL 0.39, MetaLR 0.03
- Y52Y (p.Tyr52Tyr), rs756070473, gnomAD 6-26090920-C-T, CADD 0.40
- V53L (p.Val53Leu), 1000Genomes rs28934889, ESP rs28934889, ExAC rs28934889, TOPMed rs28934889, Benign
- V53M (p.Val53Met), rs28934889, ClinGen CA113801, cosmic curated COSV58512, ClinVar RCV000000032, REVEL 0.64, CADD 22.60, Uncertain significance, Hemochromatosis type 1; not provided
- D54G (p.Asp54Gly), TOPMed rs1187279903, gnomAD rs1187279903, REVEL 0.79, CADD 27.10
- D54Y (p.Asp54Tyr), Ensembl rs1762651132
- D54D (p.Asp54Asp), gnomAD 6-26090926-T-C, CADD 1.34
- D55H (p.Asp55His), TOPMed rs1762651725
- Q56H (p.Gln56His), TOPMed rs1762651942, gnomAD rs1762651942, REVEL 0.13, CADD 13.90
- Q56* (p.Gln56Ter), gnomAD 6-26090930-C-T, CADD 35.00
- L57M (p.Leu57Met), ExAC rs777817599, gnomAD rs777817599
- L57Q (p.Leu57Gln), gnomAD 6-26090934-T-A, REVEL 0.30, MetaLR 0.27
- L57L (p.Leu57Leu), rs1398948148, gnomAD 6-26090935-G-C, CADD 6.00
- F58L (p.Phe58Leu), gnomAD rs1430881888, REVEL 0.21, CADD 25.70
- F58F (p.Phe58Phe), rs147297176, gnomAD 6-26090938-C-T, CADD 0.84
- V59A (p.Val59Ala), TOPMed rs1467801632, gnomAD rs1467801632, REVEL 0.30, CADD 24.70
- V59M (p.Val59Met), rs111033557, ClinGen CA113804, cosmic curated COSV10035, ClinVar RCV000000033, REVEL 0.27, CADD 24.00, Uncertain significance, not specified; Hemochromatosis type 1
- V59V (p.Val59Val), gnomAD 6-26090941-G-T, CADD 7.37
- F60L (p.Phe60Leu), cosmic curated COSV10881, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F60Y (p.Phe60Tyr), gnomAD 6-26090943-T-A, REVEL 0.06, MetaLR 0.00
- Y61C (p.Tyr61Cys), rs1684658845, ClinGen CA363204700, ClinVar RCV002012999, Ensembl rs1684658845, REVEL 0.55, CADD 25.60, Uncertain significance, Hereditary hemochromatosis
- Y61H (p.Tyr61His), gnomAD 6-26090945-T-C, REVEL 0.49, MetaLR 0.90
- Y61* (p.Tyr61Ter), gnomAD 6-26090947-T-G, CADD 33.00
- D62Y (p.Asp62Tyr), TOPMed rs977937170
- H63D (p.His63Asp), rs1799945, ClinGen CA113797, cosmic curated COSV58513, ClinVar RCV000000026, REVEL 0.32, CADD 15.60, Conflicting classifications of pathogenicity; ot, Hemochromatosis type 1; TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; Micr
- H63Y (p.His63Tyr), 1000Genomes rs1799945, ESP rs1799945, ExAC rs1799945, TOPMed rs1799945, Pathogenic, in HFE1
- H63P (p.His63Pro), gnomAD 6-26090952-A-C, REVEL 0.35, MetaLR 0.63
- H63H (p.His63His), rs147426902, gnomAD 6-26090953-T-C, CADD 5.21
- E64D (p.Glu64Asp), 1000Genomes rs556335391, ExAC rs556335391, gnomAD rs556335391, REVEL 0.20, CADD 23.60, Likely benign
- E64Q (p.Glu64Gln), Ensembl rs1581666690, REVEL 0.25, CADD 25.30
- S65C (p.Ser65Cys), rs1800730, ClinGen CA339778, ClinVar RCV000000028, ClinVar RCV000290779, REVEL 0.55, CADD 26.00, Likely pathogenic, Hemochromatosis type 1
- R66C (p.Arg66Cys), rs747739169, ClinGen CA3666607, NCI-TCGA Cosmic COSV5851, cosmic curated COSV58513, REVEL 0.44, CADD 25.30, Uncertain significance, not specified; Hemochromatosis type 1; not provided
- R66H (p.Arg66His), rs771912764, NCI-TCGA Cosmic COSV5851, cosmic curated COSV58513, ExAC rs771912764, REVEL 0.32, CADD 23.10, Variant assessed as somatic; moderate impact., in HFE1
- R66R (p.Arg66Arg), gnomAD 6-26090962-C-T, CADD 6.64
- R67C (p.Arg67Cys), rs772818312, ClinGen CA3666609, NCI-TCGA Cosmic COSV5851, cosmic curated COSV58512, REVEL 0.20, CADD 23.70, Conflicting interpretations, not specified; Hereditary hemochromatosis
- R67H (p.Arg67His), rs139523708, ClinGen CA3666610, ClinVar RCV001766063, ClinVar RCV004988739, REVEL 0.11, CADD 17.30, Uncertain significance, not provided; Inborn genetic diseases
- R67L (p.Arg67Leu), rs139523708, ClinGen CA354217, NCI-TCGA Cosmic COSV5851, cosmic curated COSV58512, REVEL 0.09, CADD 22.10, Uncertain significance, Hemochromatosis type 1
- R67G (p.Arg67Gly), gnomAD 6-26090963-C-G, REVEL 0.11, MetaLR 0.00
- V68M (p.Val68Met), rs776668429, ClinGen CA3666611, ClinVar RCV003485839, ExAC rs776668429, AlphaMissense 0.39, MetaLR 0.25, Uncertain significance, Hemochromatosis type 1
- V68E (p.Val68Glu), gnomAD 6-26090967-T-A, REVEL 0.18, MetaLR 0.22
- E69V (p.Glu69Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P70L (p.Pro70Leu), TOPMed rs1762656782
- P70T (p.Pro70Thr), gnomAD rs1263353185, REVEL 0.27, CADD 10.80
- P70S (p.Pro70Ser), gnomAD 6-26090972-C-T, REVEL 0.12, MetaLR 0.46
- R71* (p.Arg71Ter), rs759524388, ClinGen CA3666612, ClinVar RCV001387126, ClinVar RCV003127860, CADD 33.00, Pathogenic
- R71Q (p.Arg71Gln), rs776741897, ClinGen CA3666613, NCI-TCGA Cosmic COSV5851, cosmic curated COSV58512, REVEL 0.27, CADD 17.40, Uncertain significance, not provided; Hemochromatosis type 1
- R71R (p.Arg71Arg), gnomAD 6-26090977-A-G, CADD 0.29
- T72A (p.Thr72Ala), gnomAD rs1314720488, REVEL 0.05, CADD 0.48
- T72T (p.Thr72Thr), rs1249280724, gnomAD 6-26090980-T-A, CADD 1.52
- P73A (p.Pro73Ala), rs1450662478, ClinGen CA363205737, ClinVar RCV003215169, TOPMed rs1450662478, REVEL 0.09, CADD 4.82, Uncertain significance, Inborn genetic diseases
- P73T (p.Pro73Thr), rs1450662478, NCI-TCGA Cosmic COSV5851, cosmic curated COSV58512, TOPMed rs1450662478, REVEL 0.10, CADD 11.90, Uncertain significance
- P73P (p.Pro73Pro), gnomAD 6-26090983-A-G, CADD 0.30
- W74* (p.Trp74Ter), gnomAD rs1762658380, CADD 36.00
Public HFE analysis runs
- HFE analysis run — HFE (681 variants) — completed 2026-08-10